[HTML][HTML] Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: evidence from an FDA pooled analysis of landmark clinical …
…, M Navaid, CJ Lee, PC Lee, A Bulumulle… - European Journal of …, 2021 - Elsevier
Purpose The development of treatment-related adverse events (trAE) correlates favorably
with clinical outcomes in multiple studies of patients receiving immune checkpoint inhibitors (…
with clinical outcomes in multiple studies of patients receiving immune checkpoint inhibitors (…
[HTML][HTML] Emerging role of immune checkpoint blockade in pancreatic cancer
Immune checkpoint blockade (ICB) with programmed cell death protein-1(PD-1)/programmed
death ligand -1(PD-L1) antibodies has revolutionized the management of several cancers, …
death ligand -1(PD-L1) antibodies has revolutionized the management of several cancers, …
[HTML][HTML] Immunotherapy in hepatocellular cancer patients with mild to severe liver dysfunction: adjunctive role of the ALBI grade
…, M Muzaffar, M Navaid, CJ Lee, A Bulumulle… - Cancers, 2020 - mdpi.com
Immune checkpoint inhibitors (ICI) have shown positive results in patients with hepatocellular
carcinoma (HCC). As liver function contributes to prognosis, its precise assessment is …
carcinoma (HCC). As liver function contributes to prognosis, its precise assessment is …
Early antibiotic exposure is not detrimental to therapeutic effect from immunotherapy in hepatocellular carcinoma
…, U Khan, M Muzaffar, M Navaid, PC Lee, A Bulumulle… - Liver Cancer, 2021 - karger.com
Background and Rationale: Immune checkpoint inhibitor (ICI) therapy is an expanding
therapeutic option for hepatocellular carcinoma (HCC). Antibiotics (ATB) taken prior to or early …
therapeutic option for hepatocellular carcinoma (HCC). Antibiotics (ATB) taken prior to or early …
[HTML][HTML] Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
…, M Navaid, U Khan, CJ Lee, A Bulumulle… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
… Petros Fessas, 1 Ahmed Kaseb, 2 Yinghong Wang, 3 Anwaar Saeed, 4 David Szafron, 5
Tomi Jun, 6 Sirish Dharmapuri, 6 Abdul Rafeh Naqash, 7 Mahvish Muzaffar, 7 Musharraf …
Tomi Jun, 6 Sirish Dharmapuri, 6 Abdul Rafeh Naqash, 7 Mahvish Muzaffar, 7 Musharraf …
[HTML][HTML] Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
…, M Navaid, U Khan, CJ Lee, A Bulumulle… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
The impact of corticosteroid therapy (CT) on efficacy of immune checkpoint inhibitors (ICI) is
undefined in hepatocellular carcinoma (HCC). We evaluated whether CT administered at …
undefined in hepatocellular carcinoma (HCC). We evaluated whether CT administered at …
[PDF][PDF] Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
…, CJ Lee, PC Lee, A Bulumulle… - Hepatology …, 2022 - Wiley Online Library
The availability of immune checkpoint inhibitors (ICIs) for the management of advanced
hepatocellular cancer (HCC) has changed the treatment paradigm. There are emerging …
hepatocellular cancer (HCC) has changed the treatment paradigm. There are emerging …
Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer
Background Besides modeling/simulation-based analysis, no post-approval studies have
evaluated the optimal administration frequency of pembrolizumab in non–small-cell lung …
evaluated the optimal administration frequency of pembrolizumab in non–small-cell lung …
The real-world incidence of immunotherapy-related thyroid dysfunction: A retrospective analysis of a single center's experience over five years.
HM Brody, S Macherla, A Bulumulle, P Namireddy… - 2020 - ascopubs.org
98 Background: Immunotherapy related thyroid abnormalities are well described. Any grade
abnormality has been reported in 6-18% of patients. The clinical relevance of thyroid …
abnormality has been reported in 6-18% of patients. The clinical relevance of thyroid …
[HTML][HTML] Bilateral orbital myeloid sarcoma preceding acute myeloid leukemia in an adult: a case report and review of the literature
…, O Mukarram, P Nutalapati, M Mok, A Bulumulle… - Journal of Medical Case …, 2016 - Springer
Background Acute myeloid leukemia is typically a disease of the older population and
presents mostly in the fifth decade of life. Myeloid sarcoma is a rare initial presentation of acute …
presents mostly in the fifth decade of life. Myeloid sarcoma is a rare initial presentation of acute …